drugset / Trial / NCT01058941

Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease

NCT01058941

Phase 1/2 Completed 67 enrolled Oregon Health and Science University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to see if taking lipoic acid plus omega-3 fatty acids (omega-3s) can slow the Alzheimer's disease (AD) process. To see if the treatment can slow the AD process, the investigators looked at changes in memory and changes in a person's daily activities over 18 months.

Timeline

Start
2010-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fish oil concentrate Unknown 3 g Oral
Subject alpha-lipoic acid Small molecule 600 mg Oral

Indications